obesity drugs

An arrow incrementally going up stairs before pointing straight up Blue background
Biotech

Rhythm’s obesity pill trial hits primary goal, sending stock up

A phase 2 trial of the biotech’s next-generation oral candidate hit its primary endpoint, sending the stock up 26%.
Nick Paul Taylor Jul 9, 2025 10:21am
obesity drugs

MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b

Jun 24, 2025 10:06am
head to head against clash football helmets fight combat

BrightGene tops Novo drug in diabetes ahead of Zepbound showdown

Jun 23, 2025 2:30pm
china chinese Asia

Corxel, Sciwind post data as China's obesity push gathers pace

Jun 23, 2025 9:20am
Weight loss

Novo's injectable amycretin yet to hit weight loss plateau

Jun 23, 2025 4:29am
weight loss scale weigh measure tape obesity overweight

Lilly's amylin data impress with 11% weight loss, tolerability

Jun 16, 2025 4:55am